<% usuario = Request.QueryString("usuario") mf = request.QueryString("mf") %>
PRODUCT NAME: AGLUCIDE
• Active Ingredient Glicazide 80 mg.
• Description Oral hypoglycemic agent.
• Indication Diabetes Type 2.
• How Supplied Blister containing 30 tablets.
Volver
PRODUCT NAME: ANAUS
• Active Ingredient Sildenafil 50 mg.
• Description Selective inhibitor of phosphodiestarasa.
• Indication Oral therapy for erectile dysfunction.
• How Supplied Blister containing 2 and 10 coated tablets.
Volver
PRODUCT NAME: ANDROLONE
• Active Ingredient Testosterone 1%
• Description Homonal replacement therapy for men.
• Indication Treatment of deficiency of testosterone.
• How Supplied Packaging containing 15 1-aplication bags x 5 gr gel each..
Volver
PRODUCT NAME: ATEROCLAR
• Active Ingredient Atorvastatin 10, 20 and 40 mg.
• Description HMG CoA reductase inhibitor
• Indication Treatment of hyperlipidemia o dyslipidemia.
• How Supplied Blister containing 30 coated tablets each.
Volver
PRODUCT NAME: ATEROCLAR DUO
• Active Ingredient Ezetimibe / Atorvastatin.
• Description HMG CoA reductase inhibitor
• Indication Treatment of hyperlipidemia.
• How Supplied 10mg+10mg: Blister containing 15 coated tablets each (total: 30 coated tablets)
10mg+10mg: Blister containing 30 coated tablets each (total: 60 coated tablets)
10mg+20mg: Blister containing 30 coated tablets each (total: 60 coated tablets)
Volver
PRODUCT NAME: AVERTEX
• Active Ingredient Finasteride 5 mg.
• Description 5-a reductase inhibitor.
• Indication Beninge prostatic hyperplasia.
• How Supplied Blister containing 30 tablets.
Volver
PRODUCT NAME: BETASINT
• Active Ingredient Bovine and Porcine Insulin
• Description 40, 80 and 100 I.U. Regular, NPH, Lente.
• Indication Diabetes Mellitus.
• How Supplied Vials containing 10 ml.
Volver
PRODUCT NAME: BETALIN
• Active Ingredient Human Insulin
• Description 40 and 100 I.U.  Regular, NPH, Lente.
• Indication Diabetes Mellitus.
• How Supplied Vials containing 10 ml.
Cartridges x 1,5 and 3 ml.
Volver
PRODUCT NAME: BRINTENAL
• Active Ingredient Selegiline chlorhydrated 5 mg.
• Description Antiparkinsonian agent.
• Indication Parkinson's disease.
• How Supplied Blister containing 20 and 60 tablets.
Volver
PRODUCT NAME: CERCLETOL
• Active Ingredient Ezetimibe 10 mg.
• Description Treatment of Dyslipidemia.
• Indication Treatment of high levels of cholesterol.
• How Supplied Packaging containing 15 and 30 tablets.
Volver
PRODUCT NAME: CERELUC
• Active Ingredient Pioglitazone hydrochloride HCL: 15, 30 and 45 mg.
• Description oral hypoglycemic agent.
• Indication Glycemic control in patients with type 2 diabetes.
• How Supplied Blister containing 15 and 30 tablets.
Volver
PRODUCT NAME: CIPROCORT (cream)
• Active Ingredient Ketoconazole, hydrocortisone acetate and gentamicin sulfate.
• Description Antifungal and antibacterial topical cream for local action.
• Indication Contact or atopic dermatitis, bacterial and mycotic dermatoses, eczema and eczematoid lesions, intertrigo, candidiasis, pyoderma and tinea (pityriasis) versicolor, athlete's foot.
• How Supplied Cream: tube containing 20 gr.
Volver
PRODUCT NAME: CIPROCORT (spray)
• Active Ingredient Ketoconazole, hydrocortisone acetate and Gentamicin sulfate.
• Description Topical, antifungal and antibacterial agent.
• Indication Contact or atopic dermatitis, bacterial and mycotic dermatoses, eczema and eczematoid lesions, intertrigo, candidiasis, pyoderma and tinea (pityriasis) versicolor. Athlete's foot.
• How Supplied Spray with 75 grs.
Volver
PRODUCT NAME: CIPROCORT Vaginal Suppositories
• Active Ingredient Miconazol nitrate, hydrocortisone and metronidazole 250 mg.
• Description Antimycotic, antitricomonyasic and antibacterial agent.
• Indication Vaginitis.
• How Supplied Blister containing 6 vaginal suppositories.
Volver
PRODUCT NAME: CIPROCORT 8 mg
• Active Ingredient Dexamethasone phosphate sodium 8 mg, cyproheptadine hydrochloride 1 mg.
• Description Antihistaminic, antiallergenic agent.
• Indication It is indicated for the treatment of acute allergic conditions when oral therapy is impossible or contraindicated and as an adjunct to epinephrine and other standard measures in anaphylaxis episode.
• How Supplied Package containing 5 vials.
Volver
PRODUCT NAME: CIPROCORT D
• Active Ingredient Loratadine, Pseudoefedrine sulfate.
• Description Antiallergenic and decongestive agent.
• Indication Seasonal allergic rhinitis; common cold
• How Supplied Tablets: blister containing 10 tabs.
Syrup: bottle containing 60 ml.
Volver
PRODUCT NAME: CIPROCORT L
• Active Ingredient Loratadine, Betamethasone.
• Description Antiallergenic agent.
• Indication Allergic states of moderate intensity.
• How Supplied Tablets: blister containing 10 tabs.
Syrup: Bottle containing 60 ml.
Volver
PRODUCT NAME: CIPROVIT CALCICO
• Active Ingredient Cyproheptadine hydrochloride, try-calcium phosphate, cyanocobalamin.
• Description Appetite stimulant.
• Indication Provides vitamins and calcium for the treatment of loss of appetite and anorexia.
• How Supplied Tablets: blister containing 50 tablets.
Syrup: bottle containing 120 ml.
Volver
PRODUCT NAME: CIPROVIT ENERGIZANTE
• Active Ingredient Cyproheptadine, ascorbic acid, Vitamin "A", Ginkgo biloba extract.
• Description Psychophysical improvement.
• Indication Antioxidative. Anti-stress agent. Appetite stimulant.
• How Supplied Package containing 30 coated tabs.
Volver
PRODUCT NAME: CIPROVIT MAGNESICO
• Active Ingredient Cyproheptadine, cyanocobalamin, Vitamins "A", "D2", "B1", "B2" and "B6", nicotinamide, pantothenate calcium, hexahydrated chloride magnesium.
• Description Appetite stimulant, provides vitamins and magnesium.
• Indication Treatment of body-weakness and anorexia.
• How Supplied Package containing 20 packets in granules.
Volver
PRODUCT NAME: CLAROVIL
CLAROVIL UD
• Active Ingredient Claritromicine.
• Description Macrolid synthetic antibiotic.
• Indication Bacterial infections.
• How Supplied 250 mg: packaging containing 8 and 16 coated tablets.
500 mg: packaging containing 16 coated tables.
UD: packaging containing 4 and 8 coated tablets of long relief.
Volver
PRODUCT NAME: CLARVIX
• Active Ingredient Ginkgo Biloba 80 mg.
• Description Vasoactive agent which improves the peripheral blood flow.
• Indication Treatment of conditions such as vertigo, tinnitus, motion sickness, memory alterations, language disorders, senil states.
• How Supplied Blister containing 30 and 50 film coated tablets.
Volver
PRODUCT NAME: CLONAX
CLONAX RAPID
• Active Ingredient Clonazepam.
• Description Anticonvulsivant. Ansiolitic.
• Indication Treatment of Lennox-Gastaut syndrome.
• How Supplied 0,5 - 2 mg: packaging containing 30 and 60 tablets.
1 mg: packaging containing 30 tablets.
rapid: packaging containing 30 sublingual tablets.
Volver
PRODUCT NAME: CONEXINE
• Active Ingredient Memantine 10 mg.
• Description Neuroprotector.
• Indication Treatment of moderate or severe Alzheimer disease.
• How Supplied Blister containing 30 coated tablets.
Volver
PRODUCT NAME: CRISTACLAR
• Active Ingredient Donepezil 5 and 10 mg.
• Description Cholinesterase inhibitor.
• Indication Treatment of Alzheimer Disease.
• How Supplied Blister containing 28 coated tablets each.
Volver
PRODUCT NAME: DISCRETAL
• Active Ingredient Tibolone 2,5 mg.
• Description Steroid with estrogenic properties.
• Indication Treatment of the symptoms of natural menopause or the one caused by surgery.
• How Supplied Blister containing 30 tablets.
Volver
PRODUCT NAME: DOSODOS
• Active Ingredient Butamirate citrate.
• Description Antitussive agent.
• Indication Indicated primarily for the treatment of irritant dry cough.
• How Supplied Drops: bottle containing 15 ml.
Syrup: bottle containing 120 ml.
Volver
PRODUCT NAME: DROPICINE
• Active Ingredient Risperidone.
• Description Anti-psicotic agent.
• Indication Treatment of shizophrenia.
• How Supplied 0,5 mg: packaging containing 20 coated tablets.
1, 2 and 3 mg: packaging containing 20 and 60 coated tablets.
Syrup: bottle containing 30 ml.
Volver
PRODUCT NAME: ESTILOMICIN
• Active Ingredient Espiramicyne, Metronidazol.
• Description Antibiotic.
• Indication Odontological infections.
• How Supplied Blister containing 20 tablets.
Volver
PRODUCT NAME: ETACRIL
• Active Ingredient Cisapride 5 and 10 mg.
• Description Gastrointestinal prokinetic agent.
• Indication Symptomatic GERD (Gastroesophageal reflux disease).
• How Supplied Tablets: blister containing 20 and 40 tabs.
Volver
PRODUCT NAME: FLOCUR
FLOCUR RAPID
• Active Ingredient Tolfenamic acid.
• Description Analgesic, anti-inflammatory agent.
• Indication Headache, dysmenorrhea.
• How Supplied Blister containing 15 capsules.
Rapid: Blister containing 10 tablets.
Volver
PRODUCT NAME: GINAL CENT
• Active Ingredient Centella asiatica, metronidazole, miconazole, neomicine and polimixine.
• Description Vaginal anti-micotic and anti-microbiane agent.
• Indication It is indicated in the local treatment of vulvo-vaginal micosis or infections. Treatment of the epithelial reparation of the vagina.
• How Supplied Packing containing 6 soft vaginal suppositories.
Volver
PRODUCT NAME: GLIMIDE
• Active Ingredient Rosiglitazone 4 and 8 mg.
• Description Insulin sensitizer promoter. Oral antidiabetic therapy.
• Indication Glycemic control on type 2 diabetic patients.
• How Supplied Blister containing 15 and 30 coated tablets.
Volver
PRODUCT NAME: HEGON
• Active Ingredient Zaleplon 10 mg.
• Description Non-benzodiazepinic hypnotic agent.
• Indication Treatment of sleepless condition.
• How Supplied Packaging contining 30 capsules.
Volver
PRODUCT NAME: INMUNOARTRO
• Active Ingredient Leflunomide 20 and 100 mg.
• Description Inmunemodulator. Antiproliferative and anti-inflammatory agent.
• Indication Treatment of the rheumatoid arthritis in adults.
• How Supplied 20 mg: blister containing 30 coated tabs.
100 mg: blister containing 3 coated tabs.
Volver
PRODUCT NAME: INTESUL
• Active Ingredient Mosapride.
• Description Upper GI tract motility enhancer.
• Indication Disorders related to gastroesofagic reflux. Digestive symptoms related to chronic gastritis.
• How Supplied 2,5 mg: blister containing 30 and 60 tablets.
5 mg: blister containing 30 and 60 tablets.
Volver
PRODUCT NAME: LACTAMAX
• Active Ingredient Cabergoline 0,5 mg.
• Description Inhibitor of the production of prolactine.
• Indication Inhibitor and/or supresor of physiological lactancy.
• How Supplied Blister containing 2 and 8 tablets.
Volver
PRODUCT NAME: LAGOTRAN
• Active Ingredient Lamotigine.
• Description Anti-epileptic agent.
• Indication Treatment of Lennox-Gastaut syndrome.
• How Supplied 25, 50 and 100 mg: Packing containing 30 dispersible tablets.
Volver
PRODUCT NAME: LISINAL
• Active Ingredient Lysinopril: 10 and 20 mg.
• Description Antihypertensive agent; ACE inhibitor.
• Indication Hypertension.
• How Supplied Blister containing 30 tablets.
Volver
PRODUCT NAME: LOTOQUIS SIMPLE
• Active Ingredient Calcium Diphenylhydantoin.
• Description Antiepyleptic, anticonvulsant.
• Indication Indicated in the treatment of several types of epilepsy.
• How Supplied Blister containing 100 tablets.
- 1 Vial x 2 ml.
Volver
PRODUCT NAME: MECANYL
• Active Ingredient Glucosamide sulfate.
• Description Anti-inflammatory and antirheumatic agent.
• Indication Primary and secondary osteoarthritis. Osteochondrosis kneecap. Chondromacacia. Periarthritis of the shoulder.
• How Supplied Oral administration 1500 mg: package containing 15 and 30 blisters with granulated powder to be prepared as oral solution.
Inyection 400 mg: Packing containing 6 ampoules ambar coloured and 6 no-coloured ampoules.
Volver
PRODUCT NAME: MECANYL DUO
• Active Ingredient Glucosamine and condroitin sulfate.
• Description Anti-inflammatory and antirheumatic agent.
• Indication Osteoarthritis. Preservation and reparation treatment of the bones destruction.
• How Supplied Packing containing 30 and 60 capsules.
Packing containing 15 and 30 packets in granules.
Volver
PRODUCT NAME: MEDILAXAN
• Active Ingredient Llanten mucilage (vegetable fibres).
• Description Normalizes the intestinal function.
• Indication Constipation.
• How Supplied Granulated fibers: bottle containing 250 gr.
Tablets: blister containing 30 tabs.
Volver
PRODUCT NAME: MOTIONAL
• Active Ingredient Psyllium 400 g.
• Description Supplement of fibres.
• Indication Chronic constipation.
• How Supplied Powder: bottles containing 400 g.
Effervescent powder: package containing 12 and 30 blisters.
Volver
PRODUCT NAME: MUCODOSODOS
• Active Ingredient Ambroxol chlorhydrated, Butamirate citrate, chlorpheniramine maleate.
• Description Antitusive, antihistaminic, mucolytic.
• Indication Acute bronchitis and allergic respiratory disorders.
• How Supplied Syrup: bottle containing 120 ml.
Volver
PRODUCT NAME: MUCODOSODOS BIOTIC
• Active Ingredient Ambroxol, Amoxicilin.
• Description Antibiotic, Antitussive and mucolytic agent.
• Indication Acute bronchitis.
• How Supplied Syrup: bottle containing 120 ml.
Volver
PRODUCT NAME: NEUREX
• Active Ingredient L